Plain balloon first and drug-eluting balloon second? The role of DCBs in arteriovenous access

Kate Steiner (Stevenage, UK) discusses existing clinical evidence on drug-coated balloons (DCBs) in the treatment of arteriovenous access stenosis—and outlines areas where further data...
avg haemodialysis access

A raft of new directions for vascular access grafts

A departure from the “extreme mantra” of Fistula First unlocks the door to a new, dynamic vision that could swing the pendulum back to...

Not always ‘the alternative’: Are arteriovenous grafts unfairly maligned?

The arteriovenous graft (AVG) for use as a dialysis conduit is a story of innovation, disappointment, intrigue, politics and hope. A recent recalibration of...

A closer look at new technologies in malignant ureteric obstruction

Malignant ureteric obstruction (MUO) poses several tangible threats to cancer patients—and these threats translate, in turn, to challenges for the interventional radiologist and other...

Matteo Tozzi

Charmaine Lok

Alexandros Mallios